An oncolytic adenovirus enhanced for Toll-like receptor 9 stimulation increases anti-tumor immune responses and reduces myeloid-derived suppressor cell activity

被引：0

作者：

Cerullo, V. ^{[1
]}

Diaconu, I. ^{[1
]}

Vaha-Koskela, M. ^{[1
]}

Romano, V. ^{[1
]}

Ugolini, M. ^{[1
]}

Rouvinen-Lagerstrom, N. ^{[1
]}

Escutenaire, S. ^{[1
]}

Holm, S-L ^{[1
]}

Pesonen, S. ^{[1
]}

Vile, R. ^{[2
]}

Kanerva, A. ^{[1
]}

Hemminki, A. ^{[1
]}

机构：

[1] Univ Helsinki, Canc Gene Therapy Grp, FIN-00290 Helsinki, Finland

[2] Mayo Clin, Dept Immunol, Rochester, MN USA

来源：

HUMAN GENE THERAPY | 2011年 / 22卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：A84 / A84

页数：1

共 50 条

[31] Brain tumor cell death mediates toll-like Receptor 2 signaling and contributes to tumor regression and anti-tumor adaptive immunity
Castro, Maria G.
JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 277 - 277
[32] IMPACT OF SD-101, A TOLL-LIKE RECEPTOR 9 CLASS C (TLR9C), AGONIST ON MYELOID DERIVED SUPPRESSOR CELLS
Ghosh, Chandra
Katz, Steven
Ghosh, Chandra
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1208 - A1208
[33] Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy
Adeshakin, Adeleye O.
Yan, Dehong
Zhang, Mengqi
Wang, Lulu
Adeshakin, Funmilayo O.
Liu, Wan
Wan, Xiaochun
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (03) : 604 - 611
[34] Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Kuo, Tracy C.
Chen, Amy
Harrabi, Ons
Sockolosky, Jonathan T.
Zhang, Anli
Sangalang, Emma
Doyle, Laura, V
Kauder, Steven E.
Fontaine, Danielle
Bollini, Sangeetha
Han, Bora
Fu, Yang-Xin
Sim, Janet
Pons, Jaume
Wan, Hong, I
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[35] Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Tracy C. Kuo
Amy Chen
Ons Harrabi
Jonathan T. Sockolosky
Anli Zhang
Emma Sangalang
Laura V. Doyle
Steven E. Kauder
Danielle Fontaine
Sangeetha Bollini
Bora Han
Yang-Xin Fu
Janet Sim
Jaume Pons
Hong I. Wan
Journal of Hematology & Oncology, 13
[36] Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice
Sherwani, Mohammad Asif
Abdelgawad, Ahmed
Chung, Minh
Ibrahim, Saad
Eraslan, Mualla
Elmets, Craig A.
Yusuf, Nabiha
CANCERS, 2021, 13 (21)
[37] Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administration
Hao, Yanyun
Li, Hui
Ge, Xiaoyan
Liu, Yang
Li, Xia
Liu, Yutong
Chen, Hongfei
Zhang, Shiying
Zou, Jing
Huang, Lingling
Zhao, Fabao
Kang, Dongwei
De Geest, Bruno G.
Zhang, Zhiyue
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (12)
[38] Targeting Toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients
Ren, Tao
Wen, Zhen-Ke
Liu, Zhong-Min
Qian, Cheng
Liang, Yong-Jie
Jin, Mei-Ling
Cai, Ying-Yun
Xu, Lin
CANCER INVESTIGATION, 2008, 26 (05) : 448 - 455
[39] Anti-Tumor Immune Responses of Oncolytic Vaccinia Virus are Synergistically Enhanced by Induction of Cell-Cell Fusion and Delivery of Multiple Immunomodulators
Nakatake, Motomu
Kaitsurumaru, Emi
Kurosaki, Hajime
Nakamura, Takafumi
MOLECULAR THERAPY, 2024, 32 (04) : 196 - 197
[40] Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells
Tsukamoto, Hiroki
Kozakai, Sao
Kobayashi, Yohei
Takanashi, Risako
Aoyagi, Takuya
Numasaki, Muneo
Ohta, Shoichiro
Tomioka, Yoshihisa
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (04) : 546 - 563

← 1 2 3 4 5 →